Effect of captopril on post-infarction remodelling visualized by light sheet microscopy and echocardiography.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 03 2021
04 03 2021
Historique:
received:
15
01
2021
accepted:
22
02
2021
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Angiotensin converting enzyme inhibitors, among them captopril, improve survival following myocardial infarction (MI). The mechanisms of captopril action remain inadequately understood due to its diverse effects on multiple signalling pathways at different time periods following MI. Here we aimed to establish the role of captopril in late-stage post-MI remodelling. Left anterior descending artery (LAD) ligation or sham surgery was carried out in male C57BL/6J mice. Seven days post-surgery LAD ligated mice were allocated to daily vehicle or captopril treatment continued over four weeks. To provide comprehensive characterization of the changes in mouse heart following MI a 3D light sheet imaging method was established together with automated image analysis workflow. The combination of echocardiography and light sheet imaging enabled to assess cardiac function and the underlying morphological changes. We show that delayed captopril treatment does not affect infarct size but prevents left ventricle dilation and hypertrophy, resulting in improved ejection fraction. Quantification of lectin perfused blood vessels showed improved vascular density in the infarct border zone in captopril treated mice in comparison to vehicle dosed control mice. These results validate the applicability of combined echocardiographic and light sheet assessment of drug mode of action in preclinical cardiovascular research.
Identifiants
pubmed: 33664407
doi: 10.1038/s41598-021-84812-7
pii: 10.1038/s41598-021-84812-7
pmc: PMC7933438
doi:
Substances chimiques
Angiotensin-Converting Enzyme Inhibitors
0
Captopril
9G64RSX1XD
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5241Références
Dzau, V. J. et al. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N. Engl. J. Med. 302, 1373–1379 (1980).
pubmed: 6246425
doi: 10.1056/NEJM198006193022501
Davis, R., Ribner, H. S., Keung, E., Sonnenblick, E. H. & Lejemtel, T. H. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. N. Engl. J. Med. 301, 117–121 (1979).
pubmed: 221810
doi: 10.1056/NEJM197907193010301
Turini, G. A., Brunner, H. R., Gribic, M., Waeber, B. & Gavras, H. Improvement of chronic congestive heart-failure by oral captopril. The Lancet 313, 1213–1215 (1979).
doi: 10.1016/S0140-6736(79)91897-X
Pfeffer, M. A. et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327, 669–677 (1992).
pubmed: 1386652
doi: 10.1056/NEJM199209033271001
Givertz, M. M. Manipulation of the Renin–Angiotensin system. Circulation 104, e14 (2001).
pubmed: 11479264
doi: 10.1161/hc3001.094733
Hanif, K., Bid, H. K. & Konwar, R. Reinventing the ACE inhibitors: Some old and new implications of ACE inhibition. Hypertens. Res. 33, 11–21 (2010).
pubmed: 19911001
doi: 10.1038/hr.2009.184
Thai, H. M., Van, H. T., Gaballa, M. A., Goldman, S. & Raya, T. E. Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. Am. J. Physiol. Heart Circ. Physiol. 276, H873 (1999).
doi: 10.1152/ajpheart.1999.276.3.H873
Ma, T. K. W., Kam, K. K. H., Yan, B. P. & Lam, Y. Y. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: Current status. Br. J. Pharmacol. 160, 1273–1292 (2010).
pubmed: 20590619
pmcid: 2938800
doi: 10.1111/j.1476-5381.2010.00750.x
Patten, R. D. et al. Ventricular remodeling in a mouse model of myocardial infarction. Am. J. Physiol. Heart. Circ. Physiol. 274, H812 (1998).
doi: 10.1152/ajpheart.1998.274.5.H1812
Pfeffer, J. M., Pfeffer, M. A. & Braunwald, E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ. Res. 57, 84–95 (1985).
pubmed: 3891127
doi: 10.1161/01.RES.57.1.84
Pfeffer, M. A., Pfeffer, J. M., Steinberg, C. & Finn, P. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril. Circulation 72, 406–412 (1985).
pubmed: 3891136
doi: 10.1161/01.CIR.72.2.406
Gould, K. E. et al. Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure. Am. J. Physiol.-Heart Circ. Physiol. 282, H615–H621 (2002).
pubmed: 11788410
doi: 10.1152/ajpheart.00206.2001
Bauer, M. et al. Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ. Res. 108, 908–916 (2011).
pubmed: 21372284
pmcid: 3376717
doi: 10.1161/CIRCRESAHA.110.239574
Giordano, F. J. et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat. Med. 2, 534–539 (1996).
pubmed: 8616711
doi: 10.1038/nm0596-534
van der Laan, A. M., Piek, J. J. & van Royen, N. Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat. Rev. Cardiol. 6, 515–523 (2009).
pubmed: 19528962
doi: 10.1038/nrcardio.2009.103
Fordyce, C. B., Gersh, B. J., Stone, G. W. & Granger, C. B. Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury. Trends Pharmacol. Sci. 36, 605–616 (2015).
pubmed: 26148636
doi: 10.1016/j.tips.2015.06.004
Zhao, T., Zhao, W., Chen, Y., Ahokas, R. A. & Sun, Y. Vascular endothelial growth factor (VEGF)-a: role on cardiac angiogenesis following myocardial infarction. Microvasc. Res. 80, 188–194 (2010).
pubmed: 20362592
pmcid: 3628688
doi: 10.1016/j.mvr.2010.03.014
Kobayashi, K. et al. Dynamics of angiogenesis in ischemic areas of the infarcted heart. Sci. Rep. 7, 1–13 (2017).
doi: 10.1038/s41598-017-07524-x
Factor, S. M., Sonnenblick, E. H. & Kirk, E. S. The histologic border zone of acute myocardial infarction. Islands or peninsulas?. Am. J. Pathol. 92, 111–124 (1978).
pubmed: 686143
pmcid: 2018602
Renier, N. et al. iDISCO: A simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159, 896–910 (2014).
pubmed: 25417164
doi: 10.1016/j.cell.2014.10.010
Susaki, E. A. et al. Advanced CUBIC protocols for whole-brain and whole-body clearing and imaging. Nat. Protoc. 10, 1709–1727 (2015).
pubmed: 26448360
doi: 10.1038/nprot.2015.085
Chung, K. et al. Structural and molecular interrogation of intact biological systems. Nature 497, 332–337 (2013).
pubmed: 23575631
pmcid: 4092167
doi: 10.1038/nature12107
Zhao, S. et al. Cellular and molecular probing of intact human organs. Cell 180, 796-812.e19 (2020).
pubmed: 32059778
pmcid: 7557154
doi: 10.1016/j.cell.2020.01.030
Belle, M. et al. Tridimensional visualization and analysis of early human development. Cell 169, 161-173.e12 (2017).
pubmed: 28340341
doi: 10.1016/j.cell.2017.03.008
Gao, E. et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ. Res. 107, 1445–1453 (2010).
pubmed: 20966393
pmcid: 3005817
doi: 10.1161/CIRCRESAHA.110.223925
Robertson, R. T. et al. Use of labeled tomato lectin for imaging vasculature structures. Histochem. Cell Biol. 143, 225–234 (2014).
pubmed: 25534591
doi: 10.1007/s00418-014-1301-3
Richter, K. N. et al. Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopy. EMBO J. https://doi.org/10.15252/embj.201695709 (2018).
doi: 10.15252/embj.201695709
pubmed: 29661886
pmcid: 5983155
Ronneberger, O., Fischer, P. & Brox, T. U-net: Convolutional networks for biomedical image segmentation. in Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) vol. 9351 234–241 (Springer Verlag, 2015).
di Donato, M. et al. Left ventricular geometry in normal and post-anterior myocardial infarction patients: sphericity index and “new” conicity index comparisons. Eur. J. Cardio-Thor. Surg. 29, 1 (2006).
doi: 10.1016/j.ejcts.2006.03.002
Fan, H. et al. Apical conicity ratio: a new index on left ventricular apical geometry after myocardial infarction. J. Thorac. Cardiovasc. Surg. 140, 1402-1407.e3 (2010).
pubmed: 20381083
doi: 10.1016/j.jtcvs.2010.02.017
Cignoni, P. et al. MeshLab: an Open-Source Mesh Processing Tool. Sixth Eurographics Italian Chapter Conference 18, 129–136 (2008).
Frangi, A. F., Niessen, W. J., Vincken, K. L. & Viergever, M. A. Multiscale vessel enhancement filtering. in Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) vol. 1496 130–137 (Springer, 1998).
Hildebrand, T. & Rüegsegger, P. A new method for the model-independent assessment of thickness in three-dimensional images. J. Microsc. 185, 67–75 (1997).
doi: 10.1046/j.1365-2818.1997.1340694.x
Qi, Y. et al. FDISCO: Advanced solvent-based clearing method for imaging whole organs. Archivio di Studi Urbani e Regionali https://doi.org/10.1126/sciadv.aau8355 (2019).
doi: 10.1126/sciadv.aau8355
Pan, C. et al. Shrinkage-mediated imaging of entire organs and organisms using uDISCO. Nat. Methods 13, 859–867 (2016).
pubmed: 27548807
doi: 10.1038/nmeth.3964
Zhong, L. et al. Left ventricular regional wall curvedness and wall stress in patients with ischemic dilated cardiomyopathy. Am. J. Physiol. Heart Circ Physiol. 296, H573 (2009).
pubmed: 19122166
pmcid: 2660226
doi: 10.1152/ajpheart.00525.2008
Salgo, I. S. et al. Geometric assessment of regional left ventricular remodeling by three-dimensional echocardiographic shape analysis correlates with left ventricular function. J. Am. Soc. Echocardiogr. 25, 80–88 (2012).
pubmed: 22000777
doi: 10.1016/j.echo.2011.09.014
Ueda, H. R. et al. Tissue clearing and its applications in neuroscience. Nat. Rev. Neurosci. 21, 61–79 (2020).
pubmed: 31896771
doi: 10.1038/s41583-019-0250-1
pmcid: 8121164
Chen, J. et al. Displacement analysis of myocardial mechanical deformation (DIAMOND) reveals segmental susceptibility to doxorubicin-induced injury and regeneration. JCI Insight 4, 1 (2019).
doi: 10.1172/jci.insight.125362
Jurtz, V. I. et al. Deep learning reveals 3D atherosclerotic plaque distribution and composition. Sci. Rep. 10, 1–9 (2020).
doi: 10.1038/s41598-020-78632-4
Buglak, N. E. et al. Light sheet fluorescence microscopy as a new method for unbiased three-dimensional analysis of vascular injury. Cardiovasc. Res. https://doi.org/10.1093/cvr/cvaa037 (2020).
doi: 10.1093/cvr/cvaa037
pmcid: 7820842
Becher, T. et al. Three-dimensional imaging provides detailed atherosclerotic plaque morphology and reveals angiogenesis after carotid artery ligation. Circ. Res. 126, 619–632 (2020).
pubmed: 31914850
doi: 10.1161/CIRCRESAHA.119.315804
pmcid: 7047629
Ding, Y. et al. Multiscale light-sheet for rapid imaging of cardiopulmonary system. JCI Insight 3, 1 (2018).
doi: 10.1172/jci.insight.121396
Fei, P. et al. Cardiac light-sheet fluorescent microscopy for multi-scale and rapid imaging of architecture and function. Sci. Rep. 6, 1–12 (2016).
doi: 10.1038/srep22489
Merz, S. F. et al. Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and response. Nat. Commun. 10, 1–14 (2019).
Perens, J. et al. An optimized mouse brain atlas for automated mapping and quantification of neuronal activity using iDISCO+ and light sheet fluorescence microscopy. Neuroinformatics 1, 1–14. https://doi.org/10.1007/s12021-020-09490-8 (2020).
doi: 10.1007/s12021-020-09490-8
Salinas, C. B. G. et al. Integrated Brain Atlas for Unbiased Mapping of Nervous System Effects Following Liraglutide Treatment. Scientific Reports 8, 1 (2018).
doi: 10.1038/s41598-018-28496-6
Solomon, S. D. et al. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation 111, 3411–3419 (2005).
pubmed: 15967846
doi: 10.1161/CIRCULATIONAHA.104.508093
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F. & Braunwald, E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N. Engl. J. Med. 319, 80–86 (1988).
pubmed: 2967917
doi: 10.1056/NEJM198807143190204
Sharpe, N., Smith, H., Murphy, J. & Hannan, S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. The Lancet 331, 255–259 (1988).
doi: 10.1016/S0140-6736(88)90347-9
Spinar, J. et al. A comparison of intervention with losartan or captopril in acute myocardial infarction. Eur. J. Heart Fail. 2, 91–100 (2000).
pubmed: 10742708
doi: 10.1016/S1388-9842(99)00070-7
Jin, H. et al. Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 103, 736–742 (2001).
pubmed: 11156887
doi: 10.1161/01.CIR.103.5.736
Yoshiyama, M. et al. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice. Heart 91, 1080–1085 (2005).
pubmed: 16020603
pmcid: 1769047
doi: 10.1136/hrt.2004.035618
Franzosi, M. G. Indications for ACE inhibitors in the early treatment of acute myocardial infarction. Circulation 97, 2202–2212 (1998).
doi: 10.1161/01.CIR.97.22.2202
Mulder, P. et al. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Circulation 95, 1314–1319 (1997).
pubmed: 9054865
doi: 10.1161/01.CIR.95.5.1314
de Kam, P. J. et al. Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. J. Am. Coll. Cardiol. 36, 2047–2053 (2000).
pubmed: 11127439
doi: 10.1016/S0735-1097(00)01024-X
Kalkman, E. A. J., van Haren, P., Saxena, P. R. & Schoemaker, R. G. Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis. Eur. J. Pharmacol. 369, 339–348 (1999).
pubmed: 10225373
doi: 10.1016/S0014-2999(99)00091-6
Mujais, S. K., Fouad, F. M. & Tarazi, R. C. Reversal of left ventricular hypertrophy with captopril: heterogeneity of response among hypertensive patients. Clin. Cardiol. 6, 595–602 (1983).
pubmed: 6229379
doi: 10.1002/clc.4960061204
Rials, S. J. et al. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 96, 1330–1336 (1997).
pubmed: 9286966
doi: 10.1161/01.CIR.96.4.1330
Thavapalachandran, S. et al. Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction. Sci. Transl. Med. 12, 524 (2020).
doi: 10.1126/scitranslmed.aay2140
Volpert, O. V. et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J. Clin. Invest. 98, 671–679 (1996).
pubmed: 8698858
pmcid: 507476
doi: 10.1172/JCI118838
Gavin, T. P., Spector, D. A., Wagner, H., Breen, E. C. & Wagner, P. D. Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise. J. Appl. Physiol. 88, 1690–1697 (2000).
pubmed: 10797131
doi: 10.1152/jappl.2000.88.5.1690
Wang, D. H. & Prewitt, R. L. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 15, 68–77 (1990).
pubmed: 2403980
doi: 10.1161/01.HYP.15.1.68
Pfau, D. et al. Angiotensin receptor neprilysin inhibitor attenuates myocardial remodeling and improves infarct perfusion in experimental heart failure. Scientific Reports 9, 1–13 (2019).
doi: 10.1038/s41598-019-42113-0
van Kerckhoven, R., van Veghel, R., Saxena, P. R. & Schoemaker, R. G. Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts. Cardiovasc. Res. 61, 620–629 (2004).
pubmed: 14962492
doi: 10.1016/j.cardiores.2003.09.026
Zhang, J. Z., Xi, X., Gao, L. & Kern, T. S. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy. Curr. Eye Res. 32, 883–889 (2007).
pubmed: 17963108
doi: 10.1080/02713680701584123
Dean, R. G., Bach, L. A. & Burrell, L. M. Upregulation of cardiac insulin-like growth factor-I receptor by ACE inhibition after myocardial infarction: potential role in remodeling. J. Histochem. Cytochem. 51, 831–839 (2003).
pubmed: 12754294
doi: 10.1177/002215540305100614
Lopez-Lopez, C., LeRoith, D. & Torres-Aleman, I. Insulin-like growth factor I is required for vessel modeling in the adult brain. Proc. Natl. Acad. Sci. USA 101, 9833–9838 (2004).
pubmed: 15210967
doi: 10.1073/pnas.0400337101
pmcid: 470760